Not applicableLooking for participantsNCT06291025
What this trial is testing
Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura
Who this might be right for
Thrombotic Microangiopathies
University Hospital, Rouen 131